Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL) is a slow-progressing blood cancer characterized by the accumulation of abnormal lymphocytes. These cells, unable to perform their normal functions, crowd out the healthy bone marrow cells, leading to anemia (a reduction in red blood cells), increased susceptibility to infections (due to a reduction in healthy white blood cells), and bleeding problems (resulting from a reduction in platelets).

In the early stages, many patients have no symptoms, and the disease is often detected during a routine complete blood count. At later stages, symptoms may include fatigue, enlarged lymph nodes, weight loss, and recurrent infections.

Statistics: CLL is the most common type of leukemia in adults. It is predominantly diagnosed in individuals over the age of 70 and occurs about twice as frequently in men compared to women.

Heredity: Chronic lymphocytic leukemia (CLL) is not classified as a hereditary disease with direct transmission from generation to generation. Nevertheless, a higher incidence has been observed in certain families, suggesting a moderate genetic influence and a slightly increased risk in individuals with a family history of the disease.